기본간호학회지 (Journal of Korean Academy of Fundamentals of Nursing)

  • 제20권2호
  • /
  • Pages.147-156
  • /
  • 2013
  • /
  • 1225-9012(pISSN)
  • /
  • 2287-1802(eISSN)
기본간호학회 (Korean Academy of Fundamentals of Nursing)
권호 표지
DOI QR코드

DOI QR Code

뇌종양 환자의 보완대체요법 이용에 영향을 미치는 요인

Investigation into the Use of Complementary and Alternative Medicine and Factors Affecting Use in Korean Patients with Brain Tumors

  • 신용순 (국립창원대학교) ;
  • 이정아 (삼성서울병원 신경외과) ;
  • 배소현 (분당 서울대병원 신경외과) ;
  • 이수연 (서울성모병원 뇌종양) ;
  • 장민경 (연세대 세브란스병원 뇌종양센터)
  • 투고 : 2013.03.26
  • 심사 : 2013.04.23
  • 발행 : 2013.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The study was done to define complementary and alternative medicine (CAM) use among primary brain tumor patients and factors influencing use. Methods: The study was conducted with convenience sampling in 5 neuro-oncology centers in Seoul and Gyeonggi Province. Data were collected using a 25-item questionnaire developed by the researchers. Results: Of 250 patients approached, 231 (92.4%) agreed to participate. Overall, 26.8% of the respondents used CAM and the average cost for CAM use was 300,000 KRW. More than 72% of CAM users did not disclose CAM use to their health care professionals. The most frequently used therapy was natural products including mushrooms. Logistic regression analysis revealed that an education level of university or higher (OR=2.92, 95% CI=1.56-5.44, p=.001), unemployment (OR=1.99, 95% CI=1.04-3.80, p=.037), and WHO grade III & IV tumors (OR=2.18, 95% CI=1.07-4.72, p=.048) were significant factors influencing CAM use. Conclusion: Three out of ten brain tumor patients spend substantial sum of money for CAM. In these situations, health care professionals should be aware of this phenomenon and provide adequate information and consultation to the patients.

키워드

참고문헌

  1. Armstrong, T., Cohen, M. Z., Hess, K. R., Manning, R., Lee, E. L., Tamayo, G., et al. (2006). Complementary and alternative medicine use and quality of life in patients with primary brain tumors. Journal of Pain and Symptom Management, 32, 148-154. https://doi.org/10.1016/j.jpainsymman.2006.02.015
  2. Arthur, K., Belliard, J. C., Hardin, S. B., Knecht, K., Chen, C. S., & Montgomery, S. (2012). Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients. Integrative Cancer Therapies, 11, 232-242. http://dx.doi.org/10.1177/1534735411433832
  3. Bairati, I., Meyer, F., Gelinas, M., Fortin, A., Nabid, A., Brochet, F., et al. (2005). Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. Journal of Clinical Oncology, 23, 5805-5813. https://doi.org/10.1200/JCO.2005.05.514
  4. Bell, R. M. (2010). A review of complementary and alternative medicine practices among cancer survivors. Clinical Journal of Oncology Nursing, 14, 365-370. https://doi.org/10.1188/10.CJON.365-370
  5. Brown, P. D., Ballman, K. V., Rummans, T. A., Maurer, M. J., Sloan, J. A., Boeve, B. F., et al. (2006). Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. Journal of Neuro-Oncology, 76, 283-291. http://dx.doi.org/10.1007/s11060-005-7020-9
  6. Choi, J. Y., Chang, Y. J., Hong, Y. S., Heo, D. S., Kim, S., Lee, J. L., et al. (2012). Complementary and alternative medicine use among cancer patients at the end of life: Korean national study. Asian Pacific Journal of Cancer Prevention, 13, 1419-1424. https://doi.org/10.7314/APJCP.2012.13.4.1419
  7. Chun, S. I. (2004). Complementary alternative medicine. Seoul: Gyechuk Publishing Company.
  8. Dolecek, T. A., Propp, J. M., Stroup, N. E., & Kruchko, C. (2012). CBTRUS Statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncology, 14, v1-v49. http://dx.doi.org/10.1093/neuonc/nos218
  9. Ferreira, P. R., Fleck, J. F., Diehl, A., Barletta, D., Braga-Filho, A., Barletta, A., et al. (2004). Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial. Head and Neck, 26, 313-321. https://doi.org/10.1002/hed.10382
  10. Fox, S., Laws, E. R., Anderson F., & Farace, E. (2006). Complementary therapy use and quality of life in persons with high-grade gliomas. Journal of Neuroscience Nursing, 38, 212-220. https://doi.org/10.1097/01376517-200608000-00003
  11. Heese, O., Schmidt, M., Nickel, S., Berger, H., Goldbrunner, R., Tonn, J. C., et al. (2010). Complementary therapy use in patients with glioma: An observational study. Neurology, 75, 2229-2235. http://dx.doi.org/10.1212/WNL.0b013e31820202c6
  12. Horneber, M., Bueschel, G., Dennert, G., Less, D., Ritter, E., & Zwahlen, M. (2012). How many cancer patients use complementary and alternative medicine: A systematic review and metaanalysis. Integrative Cancer Therapies, 11, 187-203. http://dx.doi.org/10.1177/1534735411423920
  13. Kang, E., Yang, E. J., Kim, S. M., Chung, I. Y., Han, S. A., Ku, D. H., et al. (2012). Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: A descriptive study. Supportive Care in Cancer, 20, 461-473. http://dx.doi.org/10.1007/s00520-011-1094-z
  14. Karnofsky, D., & Burchenal, J. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In MacLeod CM (Ed.), Evaluation of chemotherapeutic agents (pp. 196): Columbia Univ Press.
  15. Kim, D. Y., Kim, B. S., Lee, K. H., Lee, M. A., Hong, Y. S., Shin, S. W., et al. (2008). Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine. Cancer Research and Treatment, 40, 87-92. http://dx.doi.org/10.4143/crt.2008.40.2.87
  16. Kim, M. J., Lee, S. D., Kim, D. R., Kong, Y. H., Sohn, W. S., Ki, S. S., et al. (2004). Use of complementary and alternative medicine among Korean cancer patients. Korean Journal of Internal Medicine, 19, 250-256. https://doi.org/10.3904/kjim.2004.19.4.250
  17. Ku, C. F., & Koo, M. (2012). Association of distress symptoms and use of complementary medicine among patients with cancer. Journal of Clinical Nursing, 21, 736-744. http://dx.doi.org/10.1111/j.1365-2702.2011.03884.x
  18. Lawenda, B. D., Kelly, K. M., Ladas, E. J., Sagar, S. M., Vickers, A., & Blumberg, J. B. (2008). Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Journal of the National Cancer Institute, 100, 773-783. https://doi.org/10.1093/jnci/djn148
  19. McDermott, C. L., Blough, D. K., Fedorenko, C. R., Arora, N. K., Zeliadt, S. B., Fairweather, M. E., et al. (2012). Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Supportive Care in Cancer, 20, 65-73. http://dx.doi.org/10.1007/s00520-010-1055-y
  20. Moran, M. S., Ma, S., Jagsi, R., Yang, T. I., Higgins, S. A., Weidhaas, J. B., et al. (2013). A prospective, multicenter study of complementary/ alternative medicine (CAM) utilization during definitive radiation for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 85, 40-46. http://dx.doi.org/10.1016/j.ijrobp.2012.03.025
  21. Nandy, K. (2012). Understanding and quantifying: Effect sizes. Retrieved February 14, 2013, from School of Nursing, University of California San Francisco Web site: http://nursing.ucla.edu/workfiles/research/Effect%20Size%204-9-2012.pdf
  22. National Center of Complementary and Alternative Medicine (2012). What is complementary and alternative medicine? Retrieved February 14, 2013, from the National Center of Complementary and Alternative Medicine Web site: http://nccam.nih.gov/health/whatiscam
  23. Posadzki, P., Watson, L., & Ernst, E. (2013). Herb-drug interactions: An overview of systematic reviews. British Journal of Clinical Pharmacology, 75, 603-618. http://dx. doi.org/10.1111/j.1365-2125.2012.04350.x
  24. Seo, H. S., Yang, K. S., Kim, N. Y., Kim, H. Y., & Kim, M. K. (2009). SPSS Regression analysis (3ed.). Seoul: Hannare Academy.
  25. Shih, V., Chiang, J. Y., & Chan, A. (2009). Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients. Annals of Oncology, 20, 752-757. http://dx.doi.org/10.1093/annonc/mdn659
  26. Verhoef, M. J., Hagen, N., Pelletier, G., & Forsyth, P. (1999). Alternative therapy use in neurologic diseases: Use in brain tumor patients. Neurology, 52, 617-622. https://doi.org/10.1212/WNL.52.3.617
  27. Wanchai, A., Armer, J. M., & Stewart, B. R. (2010). Complementary and alternative medicine use among women with breast cancer: A systematic review. Clinical Journal of Oncology Nursing, 14, E45-55. http://dx.doi.org/10.1188/10.CJON.E45-E55
  28. Yun, Y. H., Lee, M. K., Park, S. M., Kim, Y. A., Lee, W. J., Lee, K. S., et al. (2013). Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: A prospective cohort study. Annals of Oncology, 24, 489-494. http://dx.doi.org/10.1093/annonc/mds469

피인용 문헌

  1. The Perception and Utilization patterns of Complementary and Alternative Medicines in Patients with Fibromyalgia Syndrome vol.23, pp.3, 2016, https://doi.org/10.5953/JMJH.2016.23.3.187
  2. 한양방결합치료로 장기간 생존하고 있는 교모세포종 증례 보고 vol.39, pp.1, 2013, https://doi.org/10.13048/jkm.18008